Fluid-Screen develops chip technology for the rapid detection and identification of bacterial contamination in biotherapeutics, healthcare, and water quality monitoring. This platform enables real-time monitoring, significantly reducing the time required for quality control processes and enhancing safety in critical applications.
Funding
$1.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting bacterial contamination in biotherapeutics, healthcare, and water quality monitoring are time-consuming, delaying quality control processes and potentially compromising safety. Traditional lab testing can take days to produce results, hindering real-time decision-making and rapid response to contamination events.
Solution
Fluid-Screen offers a chip-based technology platform for rapid detection and identification of bacterial contamination. The system significantly reduces the time required for quality control, enabling real-time monitoring and faster response times. This technology supports proactive decision-making, enhancing safety in biopharmaceutical manufacturing, healthcare settings, and water quality monitoring. The platform's speed and accuracy allow for timely interventions, minimizing risks to products, patients, and consumers.
Target Audience
The primary target audience includes biopharmaceutical manufacturers, healthcare providers, and organizations responsible for water quality monitoring.
Features
- Chip-based technology for rapid bacterial detection
- Real-time monitoring capabilities
- Broad application across biotherapeutics, healthcare, and water quality monitoring
- Enables proactive decision-making based on immediate results
- Potential for use in patient diagnostics for viral and bacterial infections